A citation-based method for searching scientific literature

Paolo Girardi, Maurizio Pompili, Marco Innamorati, Michele Mancini, Gianluca Serafini, Lorenzo Mazzarini, Antonio Del Casale, Roberto Tatarelli, Ross J Baldessarini. Hum Psychopharmacol 2009
Times Cited: 47







List of co-cited articles
223 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Agomelatine, a novel intriguing antidepressant option enhancing neuroplasticity: a critical review.
Maurizio Pompili, Gianluca Serafini, Marco Innamorati, Paola Venturini, Paolo Fusar-Poli, Leo Sher, Mario Amore, Paolo Girardi. World J Biol Psychiatry 2013
50
19

Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice.
Madhukar H Trivedi, A John Rush, Stephen R Wisniewski, Andrew A Nierenberg, Diane Warden, Louise Ritz, Grayson Norquist, Robert H Howland, Barry Lebowitz, Patrick J McGrath,[...]. Am J Psychiatry 2006
14

Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
Michael J Detke, Curtis G Wiltse, Craig H Mallinckrodt, Robert K McNamara, Mark A Demitrack, Istvan Bitter. Eur Neuropsychopharmacol 2004
230
12

Duloxetine, 60 mg once daily, for major depressive disorder: a randomized double-blind placebo-controlled trial.
Michael J Detke, Yili Lu, David J Goldstein, John R Hayes, Mark A Demitrack. J Clin Psychiatry 2002
331
12

The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R).
Ronald C Kessler, Patricia Berglund, Olga Demler, Robert Jin, Doreen Koretz, Kathleen R Merikangas, A John Rush, Ellen E Walters, Philip S Wang. JAMA 2003
12

A rating scale for depression.
M HAMILTON. J Neurol Neurosurg Psychiatry 1960
12

Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis.
Andrea Cipriani, Toshiaki A Furukawa, Georgia Salanti, John R Geddes, Julian Pt Higgins, Rachel Churchill, Norio Watanabe, Atsuo Nakagawa, Ichiro M Omori, Hugh McGuire,[...]. Lancet 2009
12

Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report.
A John Rush, Madhukar H Trivedi, Stephen R Wisniewski, Andrew A Nierenberg, Jonathan W Stewart, Diane Warden, George Niederehe, Michael E Thase, Philip W Lavori, Barry D Lebowitz,[...]. Am J Psychiatry 2006
12

Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors.
F P Bymaster, L J Dreshfield-Ahmad, P G Threlkeld, J L Shaw, L Thompson, D L Nelson, S K Hemrick-Luecke, D T Wong. Neuropsychopharmacology 2001
385
10

Duloxetine 60 mg once daily dosing versus placebo in the acute treatment of major depression.
Michael J Detke, Yili Lu, David J Goldstein, Robert K McNamara, Mark A Demitrack. J Psychiatr Res 2002
248
10

A new depression scale designed to be sensitive to change.
S A Montgomery, M Asberg. Br J Psychiatry 1979
10

The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10.
D V Sheehan, Y Lecrubier, K H Sheehan, P Amorim, J Janavs, E Weiller, T Hergueta, R Baker, G C Dunbar. J Clin Psychiatry 1998
10

Duloxetine in the treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
D G S Perahia, F Wang, C H Mallinckrodt, D J Walker, M J Detke. Eur Psychiatry 2006
102
10

Duloxetine in the treatment of depression: a double-blind placebo-controlled comparison with paroxetine.
David J Goldstein, Yili Lu, Michael J Detke, Curtis Wiltse, Craig Mallinckrodt, Mark A Demitrack. J Clin Psychopharmacol 2004
231
8

Re-evaluation of the efficacy and tolerability of venlafaxine vs SSRI: meta-analysis.
S Weinmann, T Becker, M Koesters. Psychopharmacology (Berl) 2008
34
11

The economic burden of depression in the United States: how did it change between 1990 and 2000?
Paul E Greenberg, Ronald C Kessler, Howard G Birnbaum, Stephanie A Leong, Sarah W Lowe, Patricia A Berglund, Patricia K Corey-Lisle. J Clin Psychiatry 2003
875
8

Metabolism, excretion, and pharmacokinetics of duloxetine in healthy human subjects.
R J Lantz, T A Gillespie, T J Rash, F Kuo, M Skinner, H-Y Kuan, M P Knadler. Drug Metab Dispos 2003
147
6



Long-term tolerability and effectiveness of duloxetine in the treatment of major depressive disorder.
David L Dunner, Michael Wilson, Maurizio Fava, Susan Kornstein, Rodrigo Munoz, John O'Reardon, Madhukar Trivedi, Madelaine Wohlreich. Depress Anxiety 2008
14
21


Duloxetine in the prevention of relapse of major depressive disorder: double-blind placebo-controlled study.
David G Perahia, Inmaculada Gilaberte, Fujun Wang, Curtis G Wiltse, Stacy A Huckins, Jeffrey W Clemens, Stuart A Montgomery, Angel L Montejo, Michael J Detke. Br J Psychiatry 2006
66
6


Sexual functioning assessed in 4 double-blind placebo- and paroxetine-controlled trials of duloxetine for major depressive disorder.
Pedro L Delgado, Stephen K Brannan, Craig H Mallinckrodt, Pierre V Tran, Robert K McNamara, Fujun Wang, John G Watkin, Michael J Detke. J Clin Psychiatry 2005
109
6

The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phases.
Martin B Keller, Madhukar H Trivedi, Michael E Thase, Richard C Shelton, Susan G Kornstein, Charles B Nemeroff, Edward S Friedman, Alan J Gelenberg, James H Kocsis, David L Dunner,[...]. J Clin Psychiatry 2007
73
6

Duloxetine in the prevention of depressive recurrences: a randomized, double-blind, placebo-controlled trial.
David G S Perahia, Giuseppe Maina, Michael E Thase, Melissa E Spann, Fujun Wang, Daniel J Walker, Michael J Detke. J Clin Psychiatry 2009
35
8

Duloxetine in the long-term treatment of major depressive disorder.
Joel Raskin, David J Goldstein, Craig H Mallinckrodt, Margaret B Ferguson. J Clin Psychiatry 2003
97
6

Medication augmentation after the failure of SSRIs for depression.
Madhukar H Trivedi, Maurizio Fava, Stephen R Wisniewski, Michael E Thase, Frederick Quitkin, Diane Warden, Louise Ritz, Andrew A Nierenberg, Barry D Lebowitz, Melanie M Biggs,[...]. N Engl J Med 2006
688
6

Improving adherence in mood disorders: the struggle against relapse, recurrence and suicide risk.
Maurizio Pompili, Gianluca Serafini, Antonio Del Casale, Silvia Rigucci, Marco Innamorati, Paolo Girardi, Roberto Tatarelli, David Lester. Expert Rev Neurother 2009
57
6

Efficacy and safety of duloxetine 60 mg once daily in the treatment of pain in patients with major depressive disorder and at least moderate pain of unknown etiology: a randomized controlled trial.
Stephan Brecht, Christine Courtecuisse, Catherine Debieuvre, Jens Croenlein, Durisala Desaiah, Joel Raskin, Claude Petit, Koen Demyttenaere. J Clin Psychiatry 2007
68
6

Patterns of depressive symptom response in duloxetine-treated outpatients with mild, moderate or more severe depression.
R C Shelton, A Prakash, C H Mallinckrodt, M M Wohlreich, J Raskin, M J Robinson, M J Detke. Int J Clin Pract 2007
32
9

Duloxetine in the treatment of major depressive disorder: a double-blind clinical trial.
David J Goldstein, Craig Mallinckrodt, Yili Lu, Mark A Demitrack. J Clin Psychiatry 2002
256
6

Efficacy of duloxetine and selective serotonin reuptake inhibitors: comparisons as assessed by remission rates in patients with major depressive disorder.
Michael E Thase, Yili Lu Pritchett, Melissa J Ossanna, Ralph W Swindle, Jimmy Xu, Michael J Detke. J Clin Psychopharmacol 2007
89
6

An inventory for measuring depression.
A T BECK, C H WARD, M MENDELSON, J MOCK, J ERBAUGH. Arch Gen Psychiatry 1961
6

The assessment of anxiety states by rating.
M HAMILTON. Br J Med Psychol 1959
6


Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder.
Stephen K Brannan, Craig H Mallinckrodt, Eileen B Brown, Madelaine M Wohlreich, John G Watkin, Alan F Schatzberg. J Psychiatr Res 2005
142
6


Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.
A John Rush, Madhukar H Trivedi, Stephen R Wisniewski, Jonathan W Stewart, Andrew A Nierenberg, Michael E Thase, Louise Ritz, Melanie M Biggs, Diane Warden, James F Luther,[...]. N Engl J Med 2006
682
6

Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.
Ronald C Kessler, Patricia Berglund, Olga Demler, Robert Jin, Kathleen R Merikangas, Ellen E Walters. Arch Gen Psychiatry 2005
6

Venlafaxine extended release versus conventional antidepressants in the remission of depressive disorders after previous antidepressant failure: ARGOS study.
E Baca Baldomero, J Giner Ubago, C Leal Cercós, J Vallejo Ruiloba, C García Calvo, R Prieto López. Depress Anxiety 2005
51
6



Efficacy and safety of second-generation antidepressants in the treatment of major depressive disorder.
Richard A Hansen, Gerald Gartlehner, Kathleen N Lohr, Bradley N Gaynes, Timothy S Carey. Ann Intern Med 2005
174
6

Efficacy, tolerability and side-effect profile of fluvoxamine for major depression: meta-analysis.
I M Omori, N Watanabe, A Nakagawa, T Akechi, A Cipriani, C Barbui, H McGuire, R Churchill, T A Furukawa. J Psychopharmacol 2009
17
17

National patterns in antidepressant medication treatment.
Mark Olfson, Steven C Marcus. Arch Gen Psychiatry 2009
482
6

Differential antidepressant symptom efficacy: placebo-controlled comparisons of duloxetine and SSRIs (fluoxetine, paroxetine, escitalopram).
Craig H Mallinckrodt, Apurva Prakash, John P Houston, Ralph Swindle, Michael J Detke, Maurizio Fava. Neuropsychobiology 2007
39
7


Remission, dropouts, and adverse drug reaction rates in major depressive disorder: a meta-analysis of head-to-head trials.
Márcio Machado, Michael Iskedjian, Inés Ruiz, Thomas R Einarson. Curr Med Res Opin 2006
81
6

Identification of differential microRNAs in cerebrospinal fluid and serum of patients with major depressive disorder.
Yunqiang Wan, Yuanhui Liu, Xiaobin Wang, Jiali Wu, Kezhi Liu, Jun Zhou, Li Liu, Chunxiang Zhang. PLoS One 2015
82
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.